159 related articles for article (PubMed ID: 12109950)
21. Treatment of severe sepsis and septic shock by CHDF using a PMMA membrane hemofilter as a cytokine modulator.
Nakamura M; Oda S; Sadahiro T; Hirayama Y; Watanabe E; Tateishi Y; Nakada TA; Hirasawa H
Contrib Nephrol; 2010; 166():73-82. PubMed ID: 20472994
[TBL] [Abstract][Full Text] [Related]
22. Effect of hemodiafiltration therapy in a low-birthweight infant with congenital sepsis.
Tokumasu H; Watabe S; Tokumasu S
Pediatr Int; 2016 Mar; 58(3):237-240. PubMed ID: 26669790
[TBL] [Abstract][Full Text] [Related]
23. Changes in plasma interleukin-18 by direct hemoperfusion with polymyxin B-immobilized fiber in patients with septic shock.
Nakamura T; Kawagoe Y; Suzuki T; Shoji H; Ueda Y; Kobayashi N; Koide H
Blood Purif; 2005; 23(6):417-20. PubMed ID: 16141713
[TBL] [Abstract][Full Text] [Related]
24. Polymyxin B-immobilized fiber hemoperfusion with the PMX-05R column in elderly patients suffering from septic shock.
Nakamura T; Kawagoe Y; Suzuki T; Shoji H; Ueda Y; Koide H
Am J Med Sci; 2007 Oct; 334(4):244-7. PubMed ID: 18030179
[TBL] [Abstract][Full Text] [Related]
25. Cost-effectiveness analysis of polymyxin-B immobilized fiber column and conventional medical therapy in the management of abdominal septic shock in Italy.
Berto P; Ronco C; Cruz D; Melotti RM; Antonelli M
Blood Purif; 2011; 32(4):331-40. PubMed ID: 22086346
[TBL] [Abstract][Full Text] [Related]
26. [Treatment of sepsis by extracorporeal elimination of endotoxin using fiber-immobilized polymyxin B].
Aoki H; Tani T; Hanasawa K; Shoji H; Kodama M
Nihon Geka Gakkai Zasshi; 1993 Aug; 94(8):775-80. PubMed ID: 8377751
[TBL] [Abstract][Full Text] [Related]
27. [Polymyxin-B direct hemoperfusion (PMX-DHP) in gram negative sepsis].
Perego AF; Morabito S; Graziani G; Casella GP; Parodi O
G Ital Nefrol; 2006; 23 Suppl 36():S94-102. PubMed ID: 17068736
[TBL] [Abstract][Full Text] [Related]
28. Comparison of efficacy between continuous hemodiafiltration with a PMMA membrane hemofilter and a PAN membrane hemofilter in the treatment of a patient with septic acute renal failure.
Matsuda K; Moriguchi T; Harii N; Goto J
Transfus Apher Sci; 2009 Feb; 40(1):49-53. PubMed ID: 19103511
[TBL] [Abstract][Full Text] [Related]
29. Polymyxin B-immobilized fiber column hemoperfusion therapy for septic shock.
Mitaka C; Tomita M
Shock; 2011 Oct; 36(4):332-8. PubMed ID: 21654557
[TBL] [Abstract][Full Text] [Related]
30. Online CHDF system: excellent cost-effectiveness for continuous renal replacement therapy with high efficacy and individualization.
Takatori M; Yamaoka M; Nogami S; Ojima K; Masuda T; Takeuchi S; Tada K
Contrib Nephrol; 2010; 166():173-180. PubMed ID: 20473006
[TBL] [Abstract][Full Text] [Related]
31. On-line continuous hemodiafiltration in sepsis.
Kawanishi H
Transfus Apher Sci; 2006 Dec; 35(3):265-9. PubMed ID: 17140852
[TBL] [Abstract][Full Text] [Related]
32. Continuous hemodiafiltration in children after cardiac surgery.
Watanabe K; Suzuki Y; Goto T; Yamauchi S; Daitoku K; Fukui K; Fukuda I
Artif Organs; 2011 Mar; 35(3):288-93. PubMed ID: 21091516
[TBL] [Abstract][Full Text] [Related]
33. Polymyxin B-immobilized fiber hemoperfusion attenuates increased plasma atrial natriuretic peptide and brain natriuretic Peptide levels in patients with septic shock.
Nakamura T; Suzuki T; Kawagoe Y; Koide H
ASAIO J; 2008; 54(2):210-3. PubMed ID: 18356658
[TBL] [Abstract][Full Text] [Related]
34. A longer duration of polymyxin B-immobilized fiber column hemoperfusion improves pulmonary oxygenation in patients with septic shock.
Mitaka C; Tsuchida N; Kawada K; Nakajima Y; Imai T; Sasaki S
Shock; 2009 Nov; 32(5):478-83. PubMed ID: 19295483
[TBL] [Abstract][Full Text] [Related]
35. Removal of 2-arachidonylglycerol by direct hemoperfusion therapy with polymyxin B immobilized fibers benefits patients with septic shock.
Kase Y; Obata T; Okamoto Y; Iwai K; Saito K; Yokoyama K; Takinami M; Tanifuji Y
Ther Apher Dial; 2008 Oct; 12(5):374-80. PubMed ID: 18937720
[TBL] [Abstract][Full Text] [Related]
36. Extracorporeal endotoxin removal by polymyxin B immobilized fiber cartridge: designing and antiendotoxin efficacy in the clinical application.
Shoji H; Tani T; Hanasawa K; Kodama M
Ther Apher; 1998 Feb; 2(1):3-12. PubMed ID: 10227782
[TBL] [Abstract][Full Text] [Related]
37. Effectiveness of combining plasma exchange and continuous hemodiafiltration (combined modality therapy in a parallel circuit) in the treatment of patients with acute hepatic failure.
Nakae H; Yonekawa C; Wada H; Asanuma Y; Sato T; Tanaka H
Ther Apher; 2001 Dec; 5(6):471-5. PubMed ID: 11800083
[TBL] [Abstract][Full Text] [Related]
38. Continuous hemodiafiltration with cytokine-adsorbing hemofilter in the treatment of severe sepsis and septic shock.
Hirasawa H; Oda S; Matsuda K
Contrib Nephrol; 2007; 156():365-70. PubMed ID: 17464147
[TBL] [Abstract][Full Text] [Related]
39. Combining continuous endotoxin apheresis and continuous hemodiafiltration in the treatment of patients with septic multiple organ dysfunction syndrome.
Yonekawa C; Nakae H; Tajimi K; Asanuma Y
Ther Apher Dial; 2006 Feb; 10(1):19-24. PubMed ID: 16556132
[TBL] [Abstract][Full Text] [Related]
40. Continuous hemodiafiltration using a polymethyl methacrylate membrane hemofilter for severe acute pancreatitis.
Abe R; Oda S; Shinozaki K; Hirasawa H
Contrib Nephrol; 2010; 166():54-63. PubMed ID: 20472992
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
